Single dose of magic mushroom psychedelic can cause anatomical brain changes, study finds

Single Dose of Psilocybin Linked to Lasting Anatomical Brain Changes, Researchers Report

A groundbreaking study has revealed that a single 25-milligram dose of psilocybin may trigger measurable changes in brain anatomy.

Participants, all of whom were first-time users of the psychedelic compound, underwent specialised brain scans before and after ingestion.

The research findings indicated that certain nerve tracts had become denser and more robust within just one month of taking the substance.

Scientists employed diffusion-based imaging to measure how water molecules travel along nerve bundles, thereby gauging structural integrity.

The observed neuroplasticity stood in stark contrast to the deterioration typically associated with ageing and dementia.

Were these preliminary findings to be confirmed by larger trials, they could fundamentally reshape our understanding of how psychedelics exert therapeutic effects.

Professor Robin Carhart-Harris, a neurologist at the University of California, San Francisco, emphasised the extraordinary nature of the results.

He cautioned that the precise implications of the anatomical changes remain unclear, yet he acknowledged that participants reported deeper psychological insight and enhanced wellbeing.

Not only did volunteers exhibit improved mental flexibility, but they also sustained these benefits for at least four weeks following the single dose.

The study arrives amid a surge of scientific interest in psychedelic-assisted therapies for mental health disorders.

Ongoing clinical trials are investigating whether psilocybin could offer relief for conditions ranging from treatment-resistant depression to chronic addiction.

Should subsequent research corroborate these findings, regulatory bodies may face mounting pressure to reconsider the legal status of such compounds.